---
created: 2025-04-13
updated: 2025-04-13T10:53
id: jMA:#z=xiR
specialty: hemato
specialty_id: 278
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-hematology-&-oncology::pathoma-wbc
  - source/ak-step1-v11::!flag-these-cards::sketchypathadds
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::04-pathology::28-leukemia::chronic-leukemia::chronic-lymphocytic-leukemia
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::07-leukemias-&-lymphomas::04-cll
  - "source/ak-step1-v11:": 
  - theme/sketchypath::10-myeloid-&-lymphoid::02-lymphoid-&-plasma-cell-disorders::01-acute-lymphoblastic-leukemia-(all),-chronic-lymphocytic-leukemia-(cll),-hairy-cell-leukemia-&-adult-t-cell-leukemia
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::15000-15999::15821
  - source/ak-step1-v11::^other::^expn::jbadd
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::hemeonc::jbadds"
type: flashcard
---

# Question
In CLL Chronic Lymphocytic Leukemia, neoplastic cells exhibit increased expression of **BCL2::proto-oncogene**   * Bonus: What are the main tumor promoters aka protooncogenes?

---

# Answer
CLL = lymphadenopathy, splenomegaly, and increased number of mature B-cell markers (CD20+, kappa light chains); Also, anemia, thrombocytopenia, and leukocytosis  - CLL associated with overexpression of BCL-2, an antiapoptotic protein on mitochondria. - BCL-2 inhibitors (eg, venetoclax) increase caspase activation, sensitizing cells to apoptosis. - Symptoms: lymphadenopathy, splenomegaly, mature B-cells incd *PP smear* - CLL markers: CD20+, kappa light chains.